{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:13:07Z","timestamp":1791936787279,"version":"4.3.4"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"1089","license":[{"start":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T00:00:00Z","timestamp":1453420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose of the study<\/jats:title><jats:p>Domperidone is associated with QTc prolongation, predisposing to the development of ventricular arrhythmias. In 2014, The Medicines and Healthcare Regulatory Agency (MHRA) recommended restricting its use. We assessed whether these recommendations have been implemented in a general practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study design<\/jats:title><jats:p>We conducted a prospective study using the general practitioner (GP) computer database on patients who had at least one repeat prescription for domperidone in 12\u2005months. Data were presented to the doctors and the survey was repeated 7\u2005months later.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Sixty-four patients (mean age 61.3\u00b116.4\u2005years) were identified who had received at least one repeat prescription of domperidone. Twenty patients were being prescribed over the recommended daily dose. Nineteen patients were coprescribed medications known to prolong the QTc interval and two CYP3A4 inhibitors. The repeat survey performed 7\u2005months later demonstrated a 70% reduction in the number of patients prescribed domperidone to a total of 19 (three patients prescribed above the recommended dose) none of which had a history of cardiac disease or were being coprescribed drugs known to prolong the QTc interval.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Following the publication of the MHRA recommendations and presentation of our initial survey, there has been a significant reduction in the number of patients treated with domperidone and those coprescribed drugs known to prolong the QTc interval. We suggest that regular review of GP practice database should be performed to identify those patients prescribed domperidone and at risk of life-threatening arrhythmias and measures taken to use alternative pharmacological agents.<\/jats:p><\/jats:sec>","DOI":"10.1136\/postgradmedj-2015-133645","type":"journal-article","created":{"date-parts":[[2016,6,25]],"date-time":"2016-06-25T23:39:41Z","timestamp":1466897981000},"page":"390-392","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Survey of the use of domperidone and the association with QTc prolongation in general practice"],"prefix":"10.1093","volume":"92","author":[{"given":"Adam","family":"Ioannou","sequence":"first","affiliation":[{"name":"University College London , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Jain","sequence":"additional","affiliation":[{"name":"Wrafton House Surgery , Hatfield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kassianos","sequence":"additional","affiliation":[{"name":"Ringmead Medical Practice, Birch Hill Medical Centre , Bracknell, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Missouris","sequence":"additional","affiliation":[{"name":"Cardiology, Frimley Health NHS Foundation Trust , London, UK"},{"name":"International Centre for Circulatory Health, NHLI, Imperial College , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,1,22]]},"reference":[{"key":"2023041308550411600_","volume-title":"Motilium (domperidone maleate tablets)[product monograph]","year":"2001"},{"key":"2023041308550411600_","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2165\/11536840-000000000-00000","article-title":"Domperidone and Ventricular Arrhythmia or Sudden Cardiac Death: a population-based case-control study in the Netherlands","volume":"33","author":"Van Noord","year":"2010","journal-title":"Drug Saf"},{"key":"2023041308550411600_","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/pds.2016","article-title":"Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study","author":"Johannes","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2023041308550411600_","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jpeds.2008.06.009","article-title":"Domperidone-induced QT prolongation: add another drug to the list","volume":"153","author":"Collins","year":"2008","journal-title":"J Pediatr"},{"key":"2023041308550411600_"},{"key":"2023041308550411600_"},{"key":"2023041308550411600_","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ahj.2007.01.040","article-title":"Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes","volume":"153","author":"Gupta","year":"2007","journal-title":"Am Heart J"},{"key":"2023041308550411600_"},{"key":"2023041308550411600_","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1185\/03007995.2013.840568","article-title":"QT interval prolongation and the risk of torsades de pointes: essentials for clinicians","volume":"29","author":"Trinkley","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"2023041308550411600_","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1540-8167.2006.00408.x","article-title":"QT interval: how to measure it and what is \u201cnormal.\u201d","volume":"17","author":"Goldenberg","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023041308550411600_","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","article-title":"Drug induced QT prolongation and torsades de pointes","volume":"89","author":"Yap","year":"2003","journal-title":"Heart"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/92\/1089\/390\/49846798\/postgradmedj-92-390.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/92\/1089\/390\/49846798\/postgradmedj-92-390.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:56:24Z","timestamp":1692406584000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/92\/1089\/390\/6984230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,22]]},"references-count":11,"journal-issue":{"issue":"1089","published-online":{"date-parts":[[2016,1,22]]},"published-print":{"date-parts":[[2016,7,1]]}},"URL":"https:\/\/doi.org\/10.1136\/postgradmedj-2015-133645","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,7]]},"published":{"date-parts":[[2016,1,22]]}}}